NCT03947450View on ClinicalTrials.gov

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

April 1, 2028

Study Completion Date

April 1, 2028

Conditions
AmputationSkin WoundStem Cell
Interventions
BIOLOGICAL

Autologous Skin Fibroblasts

The site or whole stump will be injected with autologous fibroblasts

BIOLOGICAL

Placebo

The site or whole stump will be injected medium only without autologous skin fibroblasts

Trial Locations (1)

21287

RECRUITING

Department of Dermatology at Johns Hopkins University, Baltimore

Sponsors
All Listed Sponsors
collaborator

Maryland Stem Cell Research Fund

UNKNOWN

collaborator

United States Department of Defense

FED

collaborator

National Institutes of Health (NIH)

NIH

lead

Johns Hopkins University

OTHER

NCT03947450 - Autologous Volar Fibroblast Injection Into the Stump Site of Amputees | Biotech Hunter | Biotech Hunter